Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease

다국어 초록 (Multilingual Abstract)

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and is strongly associated with obesity-related ectopic fat accumulation in the liver. Hepatic lipid accumulation encompasses a histological spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. Given that dysregulated hepatic lipid metabolism may be an onset factor in NAFLD, understanding how hepatic lipid metabolism is modulated in healthy subjects and which steps are dysregulated in NAFLD subjects is crucial to identify effective therapeutic targets. Additionally, hepatic inflammation is involved in chronic hepatocyte damage during NAFLD progression. As a key immune signaling hub that mediates NF-κB activation, the IκB kinase (IKK) complex, including IKKα, IKKβ, and IKKγ (NEMO), has been studied as a crucial regulator of the hepatic inflammatory response and hepatocyte survival. Notably, TANK-binding kinase 1 (TBK1), an IKK-related kinase, has recently been revealed as a potential link between hepatic inflammation and energy metabolism. Here, we review (1) the biochemical steps of hepatic lipid metabolism; (2) dysregulated lipid metabolism in obesity and NAFLD; and (3) the roles of IKKs and TBK1 in obesity and NAFLD.

참고문헌 (Reference)

1 Shelness, G. S., "Very-low-density lipoprotein assembly and secretion" 12 : 151-157, 2001

2 Yu, J., "Update on glycerol-3-phosphate acyltransferases : the roles in the development of insulin resistance" 8 : 34-, 2018

3 Khaminets, A., "Ubiquitin-dependent and independent signals in selective autophagy" 26 : 6-16, 2016

4 Alves-Bezerra, M., "Triglyceride metabolism in the liver" 8 : 1-8, 2017

5 Sharma, S., "Triggering the interferon antiviral response through an IKKrelated pathway" 300 : 1148-1151, 2003

6 Wang, Y., "Transcriptional regulation of hepatic lipogenesis" 16 : 678-689, 2015

7 Perla, F. M., "The role of lipid and lipoprotein metabolism in non-alcoholic fatty liver disease" 4 : 46-, 2017

8 Hodson, L., "The regulation of hepatic fatty acid synthesis and partitioning : the effect of nutritional state" 15 : 689-700, 2019

9 Chiang, S. H., "The protein kinase IKKepsilon regulates energy balance in obese mice" 138 : 961-975, 2009

10 McGarry, J. D., "The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis" 244 : 1-14, 1997

11 Bremer, J., "The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA" 665 : 628-631, 1981

12 Younossi, Z. M., "The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe" 64 : 1577-1586, 2016

13 Chalasani, N., "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases" 67 : 328-357, 2018

14 Luo, J. L., "The anti-death machinery in IKK/NF-kappaB signaling" 25 : 541-550, 2005

15 Smith, S., "The animal fatty acid synthase : one gene, one polypeptide, seven enzymes" 8 : 1248-1259, 1994

16 Thurston, T. L., "The TBK1adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitincoated bacteria" 10 : 1215-1221, 2009

17 Amin, N. B., "Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis" 11 : eaav9701-, 2019

18 Doege, H., "Targeted deletion of FATP5 reveals multiple functions in liver metabolism : alterations in hepatic lipid homeostasis" 130 : 1245-1258, 2006

19 Matsumoto, G., "TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1phosphorylation" 24 : 4429-4442, 2015

20 Zhao, P., "TBK1 at the crossroads of inflammation and energy homeostasis in adipose" 172 : 731-743, 2018

21 Pilli, M., "TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation" 37 : 223-234, 2012

22 Huh, J. Y., "TANK-binding kinase 1 regulates the localization of Acyl-CoA synthetase ACSL1 to control hepatic fatty acid oxidation" 32 : 1012-1027, 2020

23 Zhang, C., "Structural basis of STING binding with and phosphorylation by TBK1" 567 : 394-398, 2019

24 Donnelly, K. L., "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease" 115 : 1343-1351, 2005

25 Li, Q., "Severe liver degeneration in mice lacking the IkappaB kinase 2 gene" 284 : 321-325, 1999

26 Rudolph, D., "Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice" 14 : 854-862, 2000

27 Matsumoto, G., "Serine 403phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins" 44 : 279-289, 2011

28 Sparks, J. D., "Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia" 32 : 2104-2112, 2012

29 Zachari, M., "Selective autophagy of mitochondria on a ubiquitinendoplasmic-reticulum platform" 50 : 627-643, 2019

30 Nguyen, T. T. P., "SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice" 81 : 3820–3832.-, 2021

31 Eberle, D., "SREBP transcription factors : master regulators of lipid homeostasis" 86 : 839-848, 2004

32 Softic, S., "Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease" 61 : 1282-1293, 2016

33 Schreurs, M., "Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome" 11 : 380-388, 2010

34 Repa, J. J., "Regulation of mouse sterol regulatory element-binding protein1c gene(SREBP-1c)by oxysterol receptors, LXRalpha and LXRbeta" 14 : 2819-2830, 2000

35 Duncan, R. E., "Regulation of lipolysis in adipocytes" 27 : 79-101, 2007

36 Häcker, H., "Regulation and function of IKK and IKK-related kinases" 2006 : re13-, 2006

37 Helgason, E., "Recent insights into the complexity of Tank-binding kinase 1 signaling networks : the emerging role of cellular localization in the activation and substrate specificity of TBK1" 587 : 1230-1237, 2013

38 Rognstad, R., "Rate-limiting steps in metabolic pathways" 254 : 1875-1878, 1979

39 Browning, J. D., "Prevalence of hepatic steatosis in an urban population in the United States : impact of ethnicity" 40 : 1387-1395, 2004

40 Wild, P., "Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth" 333 : 228-233, 2011

41 Beraza, N., "Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis" 57 : 655-663, 2008

42 Seessle, J., "Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis" 1851 : 549-565, 2015

43 Tontonoz, P., "PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL" 93 : 241-252, 1998

44 Owen, M. R., "Overt and latent activities of diacylglycerol acytransferase in rat liver microsomes : possible roles in very-lowdensity lipoprotein triacylglycerol secretion" 323 : 17-21, 1997

45 Li, L. O., "Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes" 281 : 37246-37255, 2006

46 Bagnato, C., "Overexpression of diacylglycerol acyltransferase-1reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts" 278 : 52203-52211, 2003

47 Krammer, J., "Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells" 8 : 599-614, 2011

48 Weisberg, S. P., "Obesity is associated with macrophage accumulation in adipose tissue" 112 : 1796-1808, 2003

49 Lumeng, C. N., "Obesity induces a phenotypic switch in adipose tissue macrophage polarization" 117 : 175-184, 2007

50 Li, X., "Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100" 38 : 1277-1288, 1997

51 Fabbrini, E., "Obesity and nonalcoholic fatty liver disease : biochemical, metabolic, and clinical implications" 51 : 679-689, 2010

52 Kim, J. B., "Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1" 101 : 1-9, 1998

53 Gruben, N., "Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?" 1842 : 2329-2343, 2014

54 Koo, S. H., "Nonalcoholic fatty liver disease : molecular mechanisms for the hepatic steatosis" 19 : 210-215, 2013

55 Sun, S. C., "Non-canonical NF-kappaB signaling pathway" 21 : 71-85, 2011

56 Sheng, L., "NF-kappaB-inducing kinase(NIK)promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action" 18 : 943-949, 2012

57 Luedde, T., "NF-kappaB in the liver–linking injury, fibrosis and hepatocellular carcinoma" 8 : 108-118, 2011

58 Tojima, Y., "NAK is an IkappaB kinase-activating kinase" 404 : 778-782, 2000

59 Abu-Elheiga, L., "Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal" 102 : 12011-12016, 2005

60 Shen, H., "Mouse hepatocyte overexpression of NF-kappaB-inducing kinase(NIK)triggers fatal macrophage-dependent liver injury and fibrosis" 60 : 2065-2076, 2014

61 Ipsen, D. H., "Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease" 75 : 3313-3327, 2018

62 Ma, X., "Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation" 109 : 9378-9383, 2012

63 Estes, C., "Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease" 67 : 123-133, 2018

64 Pickles, S., "Mitophagy and quality control mechanisms in mitochondrial maintenance" 28 : R170-R185, 2018

65 Lou, G., "Mitophagy and neuroprotection" 26 : 8-20, 2020

66 조동형, "Mitophagy and Innate Immunity in Infection" 한국분자세포생물학회 43 (43): 10-22, 2020

67 Hammond, L. E., "Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs" 280 : 25629-25636, 2005

68 Lee, K., "Mitochondrial carnitine palmitoyltransferase 1a(CPT1a)is part of an outer membrane fatty acid transfer complex" 286 : 25655-25662, 2011

69 Adeva-Andany, M. M., "Mitochondrial beta-oxidation of saturated fatty acids in humans" 46 : 73-90, 2019

70 Wallace, D. C., "Mitochondria and cancer" 12 : 685-698, 2012

71 Miranda, P. J., "Metabolic syndrome : definition, pathophysiology, and mechanisms" 149 : 33-45, 2005

72 Abumrad, N., "Membrane proteins implicated in longchain fatty acid uptake by mammalian cells : CD36, FATP and FABPm" 1441 : 4-13, 1999

73 Coleman, R. A., "Mammalian triacylglycerol metabolism : synthesis, lipolysis, and signaling" 111 : 6359-6386, 2011

74 Soupene, E., "Mammalian long-chain acyl-CoA synthetases" 233 : 507-521, 2008

75 Young, P. A., "Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways" 293 : 16724-16740, 2018

76 Cai, D., "Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB" 11 : 183-190, 2005

77 Li, L. O., "Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition" 284 : 27816-27826, 2009

78 Mao, J., "Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis" 103 : 8552-8557, 2006

79 Higuchi, N., "Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease" 38 : 1122-1129, 2008

80 Liu, Y., "Liver NF-kappaB-inducing kinase promotes liver steatosis and glucose counterregulation in male mice with obesity" 158 : 1207-1216, 2017

81 신동욱, "Lipophagy: Molecular Mechanisms and Implications in Metabolic Disorders" 한국분자세포생물학회 43 (43): 686-693, 2020

82 Carotti, S., "Lipophagy impairment is associated with disease progression in NAFLD" 11 : 850-, 2020

83 Avramoglu, R. K., "Lipid and lipoprotein dysregulation in insulin resistant states" 368 : 1-19, 2006

84 Coleman, R. A., "It takes a village : channeling fatty acid metabolism and triacylglycerol formation via protein interactomes" 60 : 490-497, 2019

85 Mowers, J., "Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKepsilon and TBK1" 2 : e01119-, 2013

86 Shoelson, S. E., "Inflammation and insulin resistance" 116 : 1793-1801, 2006

87 Choi, S. H., "Increased very low density lipoprotein(VLDL)secretion, hepatic steatosis, and insulin resistance" 22 : 353-363, 2011

88 Chen, H. C., "Increased insulin and leptin sensitivity in mice lacking acyl CoA : diacylglycerol acyltransferase 1" 109 : 1049-1055, 2002

89 Lumeng, C. N., "Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity" 56 : 16-23, 2007

90 Trigatti, B. L., "Identification of caveolin-1 as a fatty acid binding protein" 255 : 34-39, 1999

91 Nagle, C. A., "Identification of a novel sn-glycerol-3-phosphate acyltransferase isoform, GPAT4, as the enzyme deficient in Agpat6-/-mice" 49 : 823-831, 2008

92 Seth, R. B., "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3" 122 : 669-682, 2005

93 Fitzgerald, K. A., "IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway" 4 : 491-496, 2003

94 Maeda, S., "IKKbeta is required for prevention of apoptosis mediated by cellbound but not by circulating TNFalpha" 19 : 725-737, 2003

95 Maeda, S., "IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis" 121 : 977-990, 2005

96 Kishore, N., "IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2 : comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2" 277 : 13840-13847, 2002

97 Rothwarf, D. M., "IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex" 395 : 297-300, 1998

98 Arkan, M. C., "IKK-beta links inflammation to obesity-induced insulin resistance" 11 : 191-198, 2005

99 Lin, J., "Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP" 120 : 261-273, 2005

100 Wilson, C. G., "Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice" 157 : 570-585, 2016

101 van Diepen, J. A., "Hepatocyte-specific IKK-beta activation enhances VLDLtriglyceride production in APOE*3-Leiden mice" 52 : 942-950, 2011

102 Beraza, N., "Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury" 132 : 2504-2517, 2007

103 Gluchowski, N. L., "Hepatocyte deletion of triglyceride-synthesis enzyme acyl CoA : diacylglycerol acyltransferase 2 reduces steatosis without increasing inflammation or fibrosis in mice" 70 : 1972-1985, 2019

104 Ferre, P., "Hepatic steatosis : a role for de novo lipogenesis and the transcription factor SREBP-1c" 12 : 83-92, 2010

105 Mashek, D. G., "Hepatic fatty acid trafficking : multiple forks in the road" 4 : 697-710, 2013

106 Sunami, Y., "Hepatic activation of IKK/NFkappaB signaling induces liver fibrosis via macrophage-mediated chronic inflammation" 56 : 1117-1128, 2012

107 Wunderlich, F. T., "Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis" 105 : 1297-1302, 2008

108 Wendel, A. A., "Glycerol-3-phosphate acyltransferases : rate limiting enzymes of triacylglycerol biosynthesis" 1791 : 501-506, 2009

109 Younossi, Z. M., "Global epidemiology of nonalcoholic fatty liver diseaseMeta-analytic assessment of prevalence, incidence, and outcomes" 64 : 73-84, 2016

110 Goncalves, A., "Functional dissection of the TBK1 molecular network" 6 : e23971-, 2011

111 Brandt, J. M., "Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha" 273 : 23786-23792, 1998

112 Stahl, A., "Fatty acid transport proteins : a current view of a growing family" 12 : 266-273, 2001

113 Chirala, S. S., "Fatty acid synthesis is essential in embryonic development : fatty acid synthase null mutants and most of the heterozygotes die in utero" 100 : 6358-6363, 2003

114 Syed-Abdul, M. M., "Fatty acid synthase inhibitor TVB-2640 reduces hepatic de novo lipogenesis in males with metabolic abnormalities" 72 : 103-118, 2020

115 Kim, J. H., "Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones" 276 : 24667-24673, 2001

116 Watkins, P. A., "Evidence for 26 distinct acylcoenzyme A synthetase genes in the human genome" 48 : 2736-2750, 2007

117 Tanaka, M., "Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice" 10 : 421-429, 1999

118 Saggerson, E. D., "Effects of fasting, adrenalectomy and streptozotocin-diabetes on sensitivity of hepatic carnitine acyltransferase to malonyl CoA" 129 : 225-228, 1981

119 Perry, A. K., "Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection" 199 : 1651-1658, 2004

120 Iizuka, K., "Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis" 101 : 7281-7286, 2004

121 Bonnard, M., "Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription" 19 : 4976-4985, 2000

122 Sanders, F. W., "De novo lipogenesis in the liver in health and disease : more than just a shunting yard for glucose" 91 : 452-468, 2016

123 허진영, "Crosstalk between Adipocytes and Immune Cells in Adipose Tissue Inflammation and Metabolic Dysregulation in Obesity" 한국분자세포생물학회 37 (37): 365-371, 2014

124 Mascaro, C., "Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor" 273 : 8560-8563, 1998

125 Diraison, F., "Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease" 29 : 478-485, 2003

126 Abu-Elheiga, L., "Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2" 291 : 2613-2616, 2001

127 Yamaoka, S., "Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation" 93 : 1231-1240, 1998

128 Milger, K., "Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4" 119 : 4678-4688, 2006

129 Kumashiro, N., "Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease" 108 : 16381-16385, 2011

130 Longo, N., "Carnitine transport and fatty acid oxidation" 1863 : 2422-2435, 2016

131 Dentin, R., "Carbohydrate responsive element binding protein(ChREBP)and sterol regulatory element binding protein-1c(SREBP-1c) : two key regulators of glucose metabolism and lipid synthesis in liver" 87 : 81-86, 2005

132 Singh, R., "Autophagy regulates lipid metabolism" 458 : 1131-1135, 2009

133 Chun-Seok Cho, "Autophagy Dysregulation and Obesity-Associated Pathologies" 한국분자세포생물학회 41 (41): 3-10, 2018

134 Saitoh, T., "Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response" 106 : 20842-20846, 2009

135 Vergnes, L., "Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity" 47 : 745-754, 2006

136 Choe, S. S., "Adipose tissue remodeling : its role in energy metabolism and metabolic disorders" 7 : 30-, 2016

137 Digel, M., "Acyl-CoA synthetases : fatty acid uptake and metabolic channeling" 326 : 23-28, 2009

138 Grevengoed, T. J., "Acyl-CoA metabolism and partitioning" 34 : 1-30, 2014

139 Despres, J. P., "Abdominal obesity and metabolic syndrome" 444 : 881-887, 2006

140 Seabright, A. P., "AMPK activation induces mitophagy and promotes mitochondrial fission while activating TBK1 in a PINK1-Parkin independent manner" 34 : 6284-6301, 2020

141 Muoio, D. M., "AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle : evidence that sn-glycerol-3-phosphate acyltransferase is a novel target" 338 : 783-791, 1999

142 Buque, X., "A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats" 51 : 500-513, 2010

143 Yamashita, H., "A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver" 98 : 9116-9121, 2001

144 Chakravarthy, M. V., ""New"hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis" 1 : 309-322, 2005